Induction of autophagy does not alter the anti-tumor effects of HDAC inhibitors

Cell Death and Disease

Volumn 3, Issue 9, 2012, Pages

  Newbold, A ^a   VervoortS J , ^a,c   MartinB P , ^a   Bots, M ^a,d   Johnstone, R W ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY PROTEIN 5; AUTOPHAGY PROTEIN 7; HISTONE DEACETYLASE INHIBITOR; PEPTIDES AND PROTEINS; ROMIDEPSIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; VORINOSTAT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTOPHAGY; CANCER SURVIVAL; CELL KINETICS; DRUG APPROVAL; IN VITRO STUDY; IN VIVO STUDY; LETTER; LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT RESPONSE;

ANIMALS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; AUTOPHAGY; CELL LINE, TUMOR; DEPSIPEPTIDES; HEMATOLOGIC NEOPLASMS; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; UBIQUITIN-ACTIVATING ENZYMES;

EID: 84867206267     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2012.128     Document Type: Letter

References (8)

1. Bolden JE, Peart MJ, Johnstone RW. Nat Rev Drug Discov 2006; 5: 769-784.
2. Nebbioso A et al. Nat Med 2005; 11: 77-84.
3. Lindemann RK et al. Proc Natl Acad Sci USA 2007; 104: 8071-8076.
4. Newbold A et al. Mol Cancer Ther 2008; 7: 1066-1079.
5. Ellis L et al. Blood 2009; 114: 380-393.
6. Shao Y et al. Proc Natl Acad Sci USA 2004; 101: 18030-18035.
7. Gammoh N et al. Proc Natl Acad Sci USA 2012; 109: 6561-6565.
8. Liu YL et al. Autophagy 2010; 6: 1057-1065.